- Home
- TRSG vs PULM Comparison
TRSG vs PULM Comparison
Compare TRSG & PULM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRSG
- PULM
- Stock Information
- Founded
- TRSG 1996
- PULM 2003
- Country
- TRSG Singapore
- PULM United States
- Employees
- TRSG N/A
- PULM N/A
- Industry
- TRSG
- PULM Biotechnology: Pharmaceutical Preparations
- Sector
- TRSG
- PULM Health Care
- Exchange
- TRSG NYSE
- PULM Nasdaq
- Market Cap
- TRSG 27.0M
- PULM 33.2M
- IPO Year
- TRSG 2024
- PULM N/A
- Fundamental
- Price
- TRSG $1.64
- PULM $6.50
- Analyst Decision
- TRSG
- PULM
- Analyst Count
- TRSG 0
- PULM 0
- Target Price
- TRSG N/A
- PULM N/A
- AVG Volume (30 Days)
- TRSG 6.2K
- PULM 60.7K
- Earning Date
- TRSG 05-14-2025
- PULM 08-12-2025
- Dividend Yield
- TRSG N/A
- PULM N/A
- EPS Growth
- TRSG N/A
- PULM N/A
- EPS
- TRSG N/A
- PULM N/A
- Revenue
- TRSG $12,810,249.00
- PULM $1,921,000.00
- Revenue This Year
- TRSG N/A
- PULM N/A
- Revenue Next Year
- TRSG N/A
- PULM $134.88
- P/E Ratio
- TRSG N/A
- PULM N/A
- Revenue Growth
- TRSG N/A
- PULM N/A
- 52 Week Low
- TRSG $1.00
- PULM $1.78
- 52 Week High
- TRSG $4.57
- PULM $10.40
- Technical
- Relative Strength Index (RSI)
- TRSG N/A
- PULM 39.79
- Support Level
- TRSG N/A
- PULM $6.26
- Resistance Level
- TRSG N/A
- PULM $6.96
- Average True Range (ATR)
- TRSG 0.00
- PULM 0.87
- MACD
- TRSG 0.00
- PULM -0.12
- Stochastic Oscillator
- TRSG 0.00
- PULM 40.16
About TRSG TUNGRAY TECHNOLOGIES INC
Tungray Technologies Inc is an engineer-to-order company that provides custom industrial manufacturing solutions to original equipment manufacturers in the semiconductor, printer, electronics, and home appliance industries. It predominantly generates revenue through the manufacture of custom industrial manufacturing solutions, direct drive and linear DC motors, and induction welding equipment. Geographically, the company generates a majority of its revenue from Singapore and the rest from China.
About PULM Pulmatrix Inc.
Pulmatrix Inc is a biopharmaceutical company that has focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).